anti-NGF antibody vaccine (Kennedy Institute/Jenner Institute/Latvian Biomedical Research/University of Bern)

N/A

Report date: 2025/03/18 18:10:22

Base Information

Drug Nameanti-NGF antibody vaccine (Kennedy Institute/Jenner Institute/Latvian Biomedical Research/University of Bern)
Drug Alias Nameanti-nerve growth factor antibody vaccine (Kennedy Institute of Rheumatology/Jenner Institute/Latvian Biomedical Research/University of Bern)virus-like particle vaccine (Kennedy Institute of Rheumatology/Jenner Institute/Latvian Biomedical Research/University of Bern)
ClassificationVaccines
Mechanisms of ActionNerve growth factor receptors antagonists
TargetsNerve growth factor receptors
Therapy Area/IndicationsPain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator Companiesthe Mathilda and Terrence Kennedy Institute of Rheumatology Trust
China Registration ClassN/A

Develop Information

Active Companiesthe Mathilda and Terrence Kennedy Institute of Rheumatology TrustThe Jenner InstituteUniversity Of Bern +[4] 
Inactive CompaniesN/A
Active IndicationsPain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A